• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 8300AB23A
Device Problems Fluid/Blood Leak (1250); Perivalvular Leak (1457)
Patient Problems Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
Event Date 11/29/2021
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was reported that a patient with a 23mm 8300ab aortic valve was explanted after an implant duration of two years, 10 months due to moderate to severe pvl leak.The explanted valve was replaced with a 25mm konect.
 
Event Description
It was reported that a patient with a 23mm 8300ab aortic valve was explanted after an implant duration of two years, 10 months due to moderate to severe pvl leak, central intravalvular leak, and severe aortic insufficiency.The explanted valve was replaced with a 25mm konect.Per the medical records, the patient presented with acute on chronic systolic and diastolic class iii congestive heart failure.The patient underwent a redo avr and repair of aaa with a 28mm conduit graft.The valve was removed and replaced with a 25mm konect valve without complication.Postoperatively, the patient was transferred to the cvicu.Pod #1, the patient was in complete heart block requiring ppm placement.On pod #5, the patient was discharged home with home health in stable condition.
 
Manufacturer Narrative
H10: additional manufacturer narrative: updated sections: d4 (expiration date), h4, and h6 (type of investigation, investigation findings, and investigation conclusions).The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.H11: corrective data: corrected section: h6 (component codes).Although the reported event was confirmed, the investigation could not conclusively determine the root cause.The root cause remains inconclusive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INTUITY ELITE VALVE SYSTEM
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
1 edwards way
irvine, CA 92614
9492502731
MDR Report Key13079300
MDR Text Key285544253
Report Number2015691-2021-07019
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194494
UDI-Public(01)00690103194494(17)211030
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date10/30/2021
Device Model Number8300AB23A
Device Catalogue Number8300AB23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/29/2021
Initial Date FDA Received12/23/2021
Supplement Dates Manufacturer Received01/05/2022
02/02/2022
Supplement Dates FDA Received01/28/2022
02/02/2022
Date Device Manufactured10/31/2017
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age68 YR
Patient SexFemale
-
-